JAYA BIOSCIENCES

Jaya Biosciences is a privately held pre-clinical stage life sciences company developing CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer's, Parkinson's, and frontotemporal dementia. Jaya's platform is based on the groundbreaking discovery that carriers of loss-of-function mutations in genes for lysosomal enzymes have an increased risk of neurodegeneration, including early onset of symptoms. Our science challenges the old dogma that carriers of lysosomal enzyme gene defects are normal throughout life and provides a conceptual and practical framework to treat neurodegeneration associated with these heterozygous mutations. Jaya's mission is to fulfill a promise of victory over neurodegenerative diseases by identifying and effectively targeting the relevant pathways involved in the etiology of these debilitating diseases... Jaya Biosciences is a platform company with multiple shots on goal. To date, we validated five different lysosomal..

Also known as: Jaya

Primary location: South San Francisco United States